Surgical treatment of Dupuytren's disease - outcome and health economy in relation to smoking and diabetes.

David Eckerdal; Axel Nivestam; Lars Dahlin

doi:10.1186/1471-2474-15-117

Surgical treatment of Dupuytren's disease - outcome and health economy in relation to smoking and diabetes.

David Eckerdal, Axel Nivestam, Lars Dahlin

Hand Surgery, Malmö

Research output: Contribution to journal › Article › peer-review

170 Downloads (Pure)

Abstract

The conventional treatment for Dupuytren's disease is surgery. The introduction of alternative treatment strategies creates a need to track outcomes and costs relating to surgical treatment and risk factors, such as smoking and diabetes. This was the aim of the present study.

Original language	English
Article number	117
Journal	BMC Musculoskeletal Disorders
Volume	15
Issue number	Apr 2
DOIs	https://doi.org/10.1186/1471-2474-15-117
Publication status	Published - 2014

Subject classification (UKÄ)

Orthopedics

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/1471-2474-15-117

BMC__Eckerdal_et_al

http://www.ncbi.nlm.nih.gov/pubmed/24694095?dopt=Abstract

Cite this

@article{35f4d46e62ec48b0ab59ec6f2ab8ece2,

title = "Surgical treatment of Dupuytren's disease - outcome and health economy in relation to smoking and diabetes.",

abstract = "The conventional treatment for Dupuytren's disease is surgery. The introduction of alternative treatment strategies creates a need to track outcomes and costs relating to surgical treatment and risk factors, such as smoking and diabetes. This was the aim of the present study.",

author = "David Eckerdal and Axel Nivestam and Lars Dahlin",

year = "2014",

doi = "10.1186/1471-2474-15-117",

language = "English",

volume = "15",

journal = "BMC Musculoskeletal Disorders",

issn = "1471-2474",

publisher = "BioMed Central (BMC)",

number = "Apr 2",

}

TY - JOUR

T1 - Surgical treatment of Dupuytren's disease - outcome and health economy in relation to smoking and diabetes.

AU - Eckerdal, David

AU - Nivestam, Axel

AU - Dahlin, Lars

PY - 2014

Y1 - 2014

N2 - The conventional treatment for Dupuytren's disease is surgery. The introduction of alternative treatment strategies creates a need to track outcomes and costs relating to surgical treatment and risk factors, such as smoking and diabetes. This was the aim of the present study.

AB - The conventional treatment for Dupuytren's disease is surgery. The introduction of alternative treatment strategies creates a need to track outcomes and costs relating to surgical treatment and risk factors, such as smoking and diabetes. This was the aim of the present study.

U2 - 10.1186/1471-2474-15-117

DO - 10.1186/1471-2474-15-117

M3 - Article

C2 - 24694095

SN - 1471-2474

VL - 15

JO - BMC Musculoskeletal Disorders

JF - BMC Musculoskeletal Disorders

IS - Apr 2

M1 - 117

ER -

Surgical treatment of Dupuytren's disease - outcome and health economy in relation to smoking and diabetes.

Abstract

Subject classification (UKÄ)

UN SDGs

Access to Document

Fingerprint

Cite this